4.7 Article

Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Enhanced Inflammasome Activity in Patients with Psoriasis Promotes Systemic Inflammation

Deepti Verma et al.

Summary: Psoriasis patients show increased levels of IL-1 beta and IL-18 in plasma, along with elevated expression of inflammasome sensors in peripheral blood cells. TNF-alpha activates the NLRP3 inflammasome, and anti-TNF therapy can normalize inflammasome function, potentially reducing cardiovascular risk.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Article Pharmacology & Pharmacy

DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation

Gang Bian et al.

Summary: The study found that DGT is mainly distributed in the epidermis and dermis, inhibits keratinocyte proliferation, induces apoptosis, and suppresses angiogenesis and inflammatory responses, demonstrating significant therapeutic potential for psoriasis.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

High-content screening identifies inhibitors of oxidative stress-induced parthanatos: cytoprotective and anti-inflammatory effects of ciclopirox

Zsolt Regdon et al.

Summary: The research identified ciclopirox and apomorphine as compounds that can inhibit PARP1-mediated cell death induced by hydrogen peroxide, demonstrating anti-inflammatory effects. These compounds achieve this by inhibiting PAR polymer synthesis and reducing mitochondrial superoxide production.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Immunology

The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation

Bing Wu et al.

Summary: The study showed that Activin-A plays a role in the differentiation of pathogenic Th17 cells, suggesting that the Activin-A-ALK4-ERK axis could be a therapeutic target for Th17 cell-related diseases.

IMMUNITY (2021)

Review Multidisciplinary Sciences

Function and regulation of the divisome for mitochondrial fission

Felix Kraus et al.

Summary: Mitochondria form dynamic networks through fusion and fission events, with fission serving as an endpoint event in signaling axis for cells to sense and respond to external cues. The fission process is coordinated by membrane-associated adaptors, influenced by organellar and cytoskeletal interactions, and executed by the GTPase DRP1. Separating the functional and regulatory aspects of the 'mitochondrial divisome' into core and accessory machinery provides a mechanistic understanding of the mitochondrial fission process.

NATURE (2021)

Article Multidisciplinary Sciences

The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages

Wenyun Zeng et al.

Summary: This study revealed that MCC950 attenuates atherosclerosis by inhibiting the activation of the NLRP3/ASC/Caspase-1/GSDMD-N axis, thereby reducing macrophage pyroptosis and the production of IL-1 beta and IL-18. However, MCC950 does not affect the priming of NLRP3 inflammasome activation in macrophages.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics

Soumya Ranjan Mishra et al.

Summary: The NLRP3 inflammasome plays a crucial role in neuroinflammation and neural diseases. Dysfunctional mitochondria and accumulation of mitochondrial reactive oxygen species are key factors in the activation of NLRP3 inflammasome.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)

Review Dermatology

Management of psoriasis as a systemic disease: what is the evidence?

N. J. Korman

BRITISH JOURNAL OF DERMATOLOGY (2020)

Article Pharmacology & Pharmacy

Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent

Hongxuan Feng et al.

ACTA PHARMACEUTICA SINICA B (2020)

Article Medicine, Research & Experimental

CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer

Jing Zhou et al.

THERANOSTICS (2019)

Review Immunology

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Karen V. Swanson et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Medicine, Research & Experimental

Tranilast directly targets NLRP3 to treat inflammasome-driven diseases

Yi Huang et al.

EMBO MOLECULAR MEDICINE (2018)

Review Biotechnology & Applied Microbiology

Targeting the NLRP3 inflammasome in inflammatory diseases

Matthew S. J. Mangan et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Review Allergy

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis

Andrew Blauvelt et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)

Article Cell Biology

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

Richard Gordon et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Biochemistry & Molecular Biology

PGC-1 in Melanoma: A Key Factor for Antioxidant Response and Mitochondrial Function

Margalida Torrens-Mas et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2017)

Article Medicine, Research & Experimental

BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis

Natasha Irrera et al.

CLINICAL SCIENCE (2017)

Article Multidisciplinary Sciences

ASC filament formation serves as a signal amplification mechanism for inflammasomes

Mathias S. Dick et al.

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Rebecca C. Coll et al.

NATURE MEDICINE (2015)

Article Multidisciplinary Sciences

IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3

Reiner K. W. Mailer et al.

SCIENTIFIC REPORTS (2015)

Article Biochemistry & Molecular Biology

The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation

Masahiro Okada et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Dermatology

Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid

Anna Balato et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)

Review Dermatology

The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings

David A. Martin et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Article Dermatology

Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility

Maria Carlstrom et al.

EXPERIMENTAL DERMATOLOGY (2012)

Article Multidisciplinary Sciences

A role for mitochondria in NLRP3 inflammasome activation

Rongbin Zhou et al.

NATURE (2011)

Article Multidisciplinary Sciences

Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis

Jonathan W. Jones et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells

Liying Guo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Dermatology

The activity of caspase-1 is increased in lesional psoriatic epidermis

Claus Johansen et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)

Article Dermatology

Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis

AK Gupta et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)

Article Pharmacology & Pharmacy

Ciclopirox protects mitochondria from hydrogen peroxide toxicity

SJ Lee et al.

BRITISH JOURNAL OF PHARMACOLOGY (2005)

Article Dermatology

Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist

J Shepherd et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)